Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for Depression Relapse Prevention Following ECT: a Randomised Pilot Trial With Blood Biomarker Evaluation

NCT02414932 is registered in ClinicalTrials.gov with St Patrick's Hospital, Ireland as lead sponsor.

NCT NCT02414932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02414932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for Depression Relapse Prevention Following ECT: a Randomised Pilot Trial With Blood Biomarker Evaluation
Lead sponsor
St Patrick's Hospital, Ireland
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2015
Completion date
April 7, 2017
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression